Figure 5. Validation of immune cell landscapes through scRNA-seq. (A) Integral cellular distribution between TAAD and HC cohorts; (B) The top5 corresponding cellular markers of each cell; (C, D) The comparison of cellular numbers and ratio between TAAD and HC in each cell; (E) The DEGs of TAAD in each cell. (F) the GSEA of each cell between TAAD and HC cohorts.